Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD)-Reference-Cited by-同舟云学术

Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD)

Published:2020-05-27 Issue:7 Volume:29 Page:723-738
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Calzetta Luigino¹^ORCID,Ritondo Beatrice Ludovica¹,Matera Maria Gabriella²,Pezzuto Gabriella³,Cazzola Mario¹^ORCID,Rogliani Paola¹

Affiliation:

1. Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy

2. Unit of Pharmacology, Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy

3. Division of Respiratory Medicine, University Hospital “Tor Vergata”, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1769064

Reference87 articles.

1. GOLD. 2020. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD – 2020 Report. cited 2020 Apr 22. Available from https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf

2. Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives

3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

4. Moving beyond “me-too” respiratory drugs

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval;Expert Opinion on Investigational Drugs;2023-06-03

2. The therapeutic potential of quercetin for cigarette smoking–induced chronic obstructive pulmonary disease: a narrative review;Therapeutic Advances in Respiratory Disease;2023-01

3. Systematic characterization of the effective constituents and molecular mechanisms of Ardisiae Japonicae Herba using UPLC-Orbitrap Fusion MS and network pharmacology;PLOS ONE;2022-06-15

4. Flavonoid intakes inversely associate with COPD in smokers;European Respiratory Journal;2022-01-20

5. Prospects for COPD treatment;Current Opinion in Pharmacology;2021-02